The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...
A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...
FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide ...
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...